相关实验视频
Updated: Jun 21, 2026

16:27
Strategies for Study of Neuroprotection from Cold-preconditioning
Published on: September 3, 2010
红蛋白介导的神经保护包括Jak2和NF-kappaB信号级联之间的交叉对话
1Center for Neuroscience and Aging Research, The Burnham Institute, La Jolla, CA 92037, USA.
Nature
|August 9, 2001
概括
红色素 (EPO) 预调剂通过激活神经元中的EPO受体,保护大脑细胞免受损伤. 这触发了一种新的信号通路,涉及Janus kinase-2 (Jak2) 和核因子-kappaB (NF-kappaB),防止神经元死亡.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 细胞信号传输 细胞信号传输
背景情况:
- 红色素 (EPO),主要以调节血细胞生产而闻名,也在大脑中发现.
- 缺氧诱导因子-1 (HIF-1) 在缺氧条件下增加EPO产量.
- 氧化和化应激可以诱导大脑中的EPO产生.
研究的目的:
- 在神经元损伤模型中研究EPO预调的神经保护作用.
- 阐明EPO介导的神经保护的分子机制.
- 为了确定EPO是否激活神经元中的新信号通路.
主要方法:
- 利用缺血和刺激毒性神经元损伤的模型.
- 研究了EPO受体 (EPORs) 在神经元生存中的作用.
- 研究的信号通路包括Janus激酶-2 (Jak2) 和核因子-kappaB (NF-kappaB).
- 采用了具有主导干扰Jak2和IkappaBalpha超抑制器的转染技术.
主要成果:
- 通过EPO预先调整受保护的神经元,防止NMDA和氧化 (NO) 诱导的亡.
- 神经元EPORs的激活启动了Jak2和NF-kappaB信号通路之间的交叉对话.
- 通过EPOR介导的Jak2激活导致NF-kappaB核转位和神经保护基因的转录.
- 阻断Jak2或NF-kappaB信号,取消了EPO的神经保护作用.
结论:
- 神经性EPOR激活了一个独特的神经保护通路,涉及Jak2和NF-kappaB.
- 这种EPO介导的途径可以防止由兴奋毒素和自由基诱导的亡.
- 这些发现表明,在缺氧-缺血病预调中观察到的神经保护的潜在机制.
相关概念视频
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
NF-kB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

